A study that included patients after myocardial infarction and evaluated the association between medication adherence and adverse cardiovascular events found that adherence to dual antiplatelet therapy, lipid-lowering drugs, and ACE inhibitors/ARB was significantly associated with a reduced likelihood of mortality. This evidence concerns the gene ACE and myocardial infarction.